@craigos, bit early to contemplate that mate but it wouldn't be nice....
What are we doing?......
Combo trials with keytruda....first cab off the rank
combo with chemo...the big one...Q1/20
Various trials with outlicenced pharma GSK and Novartis
Peptides with cytlimic
direct injection at an early stage..
Monash UNI collaboration news.....
Our own autoimmune ventures... among others, you get my drift..
all data for these will be a different times but as trials proceed data should become
available on a more regular basis.
One failure in a certain indication doesn't necessarily mean other trials won't succeed,
there's a way to go before we need to think about an across the board finding...
just my thoughts.....
Doldrums...., page-12
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 33.0¢ | $1.220M | 3.642M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 57289 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 52306 | 3 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |